Global Human Embryonic Stem Cell (hESC) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Human embryonic stem cell research has emerged as an important
platform for the understanding and treatment of pediatric diseases.
From its inception, however, it has raised ethical concerns based
not on the use of stem cells themselves but on objections to the source
of the cells?specifically, the destruction of preimplantation human
embryos. Despite differences in public opinion on this issue, a large
majority of the public supports continued research using embryonic
stem cells.
SCOPE OF THE REPORT:
This report studies the Human Embryonic Stem Cell (hESC) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Embryonic Stem Cell (hESC) market by product type and applications/end industries.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
The global Human Embryonic Stem Cell (hESC) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Embryonic Stem Cell (hESC).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
platform for the understanding and treatment of pediatric diseases.
From its inception, however, it has raised ethical concerns based
not on the use of stem cells themselves but on objections to the source
of the cells?specifically, the destruction of preimplantation human
embryos. Despite differences in public opinion on this issue, a large
majority of the public supports continued research using embryonic
stem cells.
SCOPE OF THE REPORT:
This report studies the Human Embryonic Stem Cell (hESC) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Embryonic Stem Cell (hESC) market by product type and applications/end industries.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
The global Human Embryonic Stem Cell (hESC) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Embryonic Stem Cell (hESC).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Astellas Institute of Regenerative Medicine (US)
- Asterias Biotherapeutics, Inc. (US)
- BD Biosciences (US)
- Cell Cure Neurosciences Ltd. (Israel)
- Cellular Dynamics International (US)
- GE Healthcare (UK)
- MilliporeSigma (US)
- PerkinElmer, Inc. (US)
- Reliance Life Sciences Ltd. (India)
- Research & Diagnostics Systems, Inc. (US)
- SABiosciences Corp. (US)
- STEMCELL Technologies, Inc. (Canada)
- Stemina Biomarker Discovery, Inc. (US)
- Takara Bio, Inc. (Japan)
- TATAA Biocenter AB (Sweden)
- Thermo Fisher Scientific, Inc. (US)
- UK Stem Cell Bank (UK)
- ViaCyte, Inc. (US)
- Vitrolife AB (Sweden)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Totipotent Stem Cell
- Pluripotent Stem Cell
- Unipotent Stem Cell
- Research
- Clinical Trials
- Others
1 HUMAN EMBRYONIC STEM CELL (HESC) MARKET OVERVIEW
1.1 Product Overview and Scope of Human Embryonic Stem Cell (hESC)
1.2 Classification of Human Embryonic Stem Cell (hESC) by Types
1.2.1 Global Human Embryonic Stem Cell (hESC) Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Types in 2017
1.2.3 Totipotent Stem Cell
1.2.4 Pluripotent Stem Cell
1.2.5 Unipotent Stem Cell
1.3 Global Human Embryonic Stem Cell (hESC) Market by Application
1.3.1 Global Human Embryonic Stem Cell (hESC) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Research
1.3.3 Clinical Trials
1.3.4 Others
1.4 Global Human Embryonic Stem Cell (hESC) Market by Regions
1.4.1 Global Human Embryonic Stem Cell (hESC) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.5 Global Market Size of Human Embryonic Stem Cell (hESC) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Astellas Institute of Regenerative Medicine (US)
2.1.1 Business Overview
2.1.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Asterias Biotherapeutics, Inc. (US)
2.2.1 Business Overview
2.2.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.3 BD Biosciences (US)
2.3.1 Business Overview
2.3.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BD Biosciences (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cell Cure Neurosciences Ltd. (Israel)
2.4.1 Business Overview
2.4.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cellular Dynamics International (US)
2.5.1 Business Overview
2.5.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.6 GE Healthcare (UK)
2.6.1 Business Overview
2.6.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.7 MilliporeSigma (US)
2.7.1 Business Overview
2.7.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.8 PerkinElmer, Inc. (US)
2.8.1 Business Overview
2.8.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Reliance Life Sciences Ltd. (India)
2.9.1 Business Overview
2.9.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Research & Diagnostics Systems, Inc. (US)
2.10.1 Business Overview
2.10.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.11 SABiosciences Corp. (US)
2.11.1 Business Overview
2.11.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.12 STEMCELL Technologies, Inc. (Canada)
2.12.1 Business Overview
2.12.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.13 Stemina Biomarker Discovery, Inc. (US)
2.13.1 Business Overview
2.13.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.14 Takara Bio, Inc. (Japan)
2.14.1 Business Overview
2.14.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.15 TATAA Biocenter AB (Sweden)
2.15.1 Business Overview
2.15.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.16 Thermo Fisher Scientific, Inc. (US)
2.16.1 Business Overview
2.16.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.17 UK Stem Cell Bank (UK)
2.17.1 Business Overview
2.17.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.18 ViaCyte, Inc. (US)
2.18.1 Business Overview
2.18.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.19 Vitrolife AB (Sweden)
2.19.1 Business Overview
2.19.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET COMPETITION, BY PLAYERS
3.1 Global Human Embryonic Stem Cell (hESC) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Embryonic Stem Cell (hESC) Players Market Share
3.2.2 Top 10 Human Embryonic Stem Cell (hESC) Players Market Share
3.3 Market Competition Trend
4 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SIZE BY REGIONS
4.1 Global Human Embryonic Stem Cell (hESC) Revenue and Market Share by Regions
4.2 North America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.3 Europe Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.5 South America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
5.1 North America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
5.2 USA Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5.3 Canada Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6 EUROPE HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
6.1 Europe Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
6.2 Germany Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.3 UK Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.4 France Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.5 Russia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.6 Italy Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
7.1 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
7.2 China Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.3 Japan Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.4 Korea Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.5 India Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
8.1 South America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
8.2 Brazil Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE HUMAN EMBRYONIC STEM CELL (HESC) BY COUNTRIES
9.1 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.3 UAE Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
10 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SEGMENT BY TYPE
10.1 Global Human Embryonic Stem Cell (hESC) Revenue and Market Share by Type (2013-2018)
10.2 Global Human Embryonic Stem Cell (hESC) Market Forecast by Type (2018-2023)
10.3 Totipotent Stem Cell Revenue Growth Rate (2013-2023)
10.4 Pluripotent Stem Cell Revenue Growth Rate (2013-2023)
10.5 Unipotent Stem Cell Revenue Growth Rate (2013-2023)
11 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SEGMENT BY APPLICATION
11.1 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Application (2013-2018)
11.2 Human Embryonic Stem Cell (hESC) Market Forecast by Application (2018-2023)
11.3 Research Revenue Growth (2013-2018)
11.4 Clinical Trials Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SIZE FORECAST (2018-2023)
12.1 Global Human Embryonic Stem Cell (hESC) Market Size Forecast (2018-2023)
12.2 Global Human Embryonic Stem Cell (hESC) Market Forecast by Regions (2018-2023)
12.3 North America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.4 Europe Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.6 South America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Human Embryonic Stem Cell (hESC)
1.2 Classification of Human Embryonic Stem Cell (hESC) by Types
1.2.1 Global Human Embryonic Stem Cell (hESC) Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Types in 2017
1.2.3 Totipotent Stem Cell
1.2.4 Pluripotent Stem Cell
1.2.5 Unipotent Stem Cell
1.3 Global Human Embryonic Stem Cell (hESC) Market by Application
1.3.1 Global Human Embryonic Stem Cell (hESC) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Research
1.3.3 Clinical Trials
1.3.4 Others
1.4 Global Human Embryonic Stem Cell (hESC) Market by Regions
1.4.1 Global Human Embryonic Stem Cell (hESC) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Embryonic Stem Cell (hESC) Status and Prospect (2013-2023)
1.5 Global Market Size of Human Embryonic Stem Cell (hESC) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Astellas Institute of Regenerative Medicine (US)
2.1.1 Business Overview
2.1.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Asterias Biotherapeutics, Inc. (US)
2.2.1 Business Overview
2.2.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.3 BD Biosciences (US)
2.3.1 Business Overview
2.3.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BD Biosciences (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cell Cure Neurosciences Ltd. (Israel)
2.4.1 Business Overview
2.4.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cellular Dynamics International (US)
2.5.1 Business Overview
2.5.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.6 GE Healthcare (UK)
2.6.1 Business Overview
2.6.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.7 MilliporeSigma (US)
2.7.1 Business Overview
2.7.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.8 PerkinElmer, Inc. (US)
2.8.1 Business Overview
2.8.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Reliance Life Sciences Ltd. (India)
2.9.1 Business Overview
2.9.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Research & Diagnostics Systems, Inc. (US)
2.10.1 Business Overview
2.10.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.11 SABiosciences Corp. (US)
2.11.1 Business Overview
2.11.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.12 STEMCELL Technologies, Inc. (Canada)
2.12.1 Business Overview
2.12.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.13 Stemina Biomarker Discovery, Inc. (US)
2.13.1 Business Overview
2.13.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.14 Takara Bio, Inc. (Japan)
2.14.1 Business Overview
2.14.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.15 TATAA Biocenter AB (Sweden)
2.15.1 Business Overview
2.15.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.16 Thermo Fisher Scientific, Inc. (US)
2.16.1 Business Overview
2.16.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.17 UK Stem Cell Bank (UK)
2.17.1 Business Overview
2.17.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.18 ViaCyte, Inc. (US)
2.18.1 Business Overview
2.18.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
2.19 Vitrolife AB (Sweden)
2.19.1 Business Overview
2.19.2 Human Embryonic Stem Cell (hESC) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET COMPETITION, BY PLAYERS
3.1 Global Human Embryonic Stem Cell (hESC) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Embryonic Stem Cell (hESC) Players Market Share
3.2.2 Top 10 Human Embryonic Stem Cell (hESC) Players Market Share
3.3 Market Competition Trend
4 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SIZE BY REGIONS
4.1 Global Human Embryonic Stem Cell (hESC) Revenue and Market Share by Regions
4.2 North America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.3 Europe Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.5 South America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
5.1 North America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
5.2 USA Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5.3 Canada Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6 EUROPE HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
6.1 Europe Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
6.2 Germany Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.3 UK Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.4 France Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.5 Russia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
6.6 Italy Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
7.1 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
7.2 China Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.3 Japan Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.4 Korea Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.5 India Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA HUMAN EMBRYONIC STEM CELL (HESC) REVENUE BY COUNTRIES
8.1 South America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
8.2 Brazil Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE HUMAN EMBRYONIC STEM CELL (HESC) BY COUNTRIES
9.1 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.3 UAE Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
10 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SEGMENT BY TYPE
10.1 Global Human Embryonic Stem Cell (hESC) Revenue and Market Share by Type (2013-2018)
10.2 Global Human Embryonic Stem Cell (hESC) Market Forecast by Type (2018-2023)
10.3 Totipotent Stem Cell Revenue Growth Rate (2013-2023)
10.4 Pluripotent Stem Cell Revenue Growth Rate (2013-2023)
10.5 Unipotent Stem Cell Revenue Growth Rate (2013-2023)
11 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SEGMENT BY APPLICATION
11.1 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Application (2013-2018)
11.2 Human Embryonic Stem Cell (hESC) Market Forecast by Application (2018-2023)
11.3 Research Revenue Growth (2013-2018)
11.4 Clinical Trials Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 GLOBAL HUMAN EMBRYONIC STEM CELL (HESC) MARKET SIZE FORECAST (2018-2023)
12.1 Global Human Embryonic Stem Cell (hESC) Market Size Forecast (2018-2023)
12.2 Global Human Embryonic Stem Cell (hESC) Market Forecast by Regions (2018-2023)
12.3 North America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.4 Europe Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.6 South America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Human Embryonic Stem Cell (hESC) Picture
Table Product Specifications of Human Embryonic Stem Cell (hESC)
Table Global Human Embryonic Stem Cell (hESC) and Revenue (Million USD) Market Split by Product Type
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Types in 2017
Figure Totipotent Stem Cell Picture
Figure Pluripotent Stem Cell Picture
Figure Unipotent Stem Cell Picture
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Application (2013-2023)
Figure Human Embryonic Stem Cell (hESC) Revenue Market Share by Applications in 2017
Figure Research Picture
Figure Clinical Trials Picture
Figure Others Picture
Table Global Market Human Embryonic Stem Cell (hESC) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Table Astellas Institute of Regenerative Medicine (US) Basic Information, Manufacturing Base and Competitors
Table Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Asterias Biotherapeutics, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table BD Biosciences (US) Basic Information, Manufacturing Base and Competitors
Table BD Biosciences (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table BD Biosciences (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Cell Cure Neurosciences Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Type and Applications
Table Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Cellular Dynamics International (US) Basic Information, Manufacturing Base and Competitors
Table Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare (UK) Basic Information, Manufacturing Base and Competitors
Table GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Type and Applications
Table GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table MilliporeSigma (US) Basic Information, Manufacturing Base and Competitors
Table MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table PerkinElmer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Life Sciences Ltd. (India) Basic Information, Manufacturing Base and Competitors
Table Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Type and Applications
Table Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Research & Diagnostics Systems, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table SABiosciences Corp. (US) Basic Information, Manufacturing Base and Competitors
Table SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table STEMCELL Technologies, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Type and Applications
Table STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Stemina Biomarker Discovery, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio, Inc. (Japan) Basic Information, Manufacturing Base and Competitors
Table Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Type and Applications
Table Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table TATAA Biocenter AB (Sweden) Basic Information, Manufacturing Base and Competitors
Table TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Type and Applications
Table TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table UK Stem Cell Bank (UK) Basic Information, Manufacturing Base and Competitors
Table UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Type and Applications
Table UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table ViaCyte, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Vitrolife AB (Sweden) Basic Information, Manufacturing Base and Competitors
Table Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Type and Applications
Table Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Players (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Players (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Players in 2016
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Players in 2017
Figure Global Top 5 Players Human Embryonic Stem Cell (hESC) Revenue Market Share in 2017
Figure Global Top 10 Players Human Embryonic Stem Cell (hESC) Revenue Market Share in 2017
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Regions (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions in 2017
Figure North America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table North America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
Table North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure USA Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Canada Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Mexico Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Europe Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Germany Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure UK Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure France Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Russia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Italy Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure China Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Japan Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Korea Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure India Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table South America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
Table South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Brazil Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Argentina Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Colombia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure UAE Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Egypt Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Nigeria Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure South Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Type (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Type (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Type (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Type in 2017
Table Global Human Embryonic Stem Cell (hESC) Revenue Forecast by Type (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Market Share Forecast by Type (2018-2023)
Figure Global Totipotent Stem Cell Revenue Growth Rate (2013-2018)
Figure Global Pluripotent Stem Cell Revenue Growth Rate (2013-2018)
Figure Global Unipotent Stem Cell Revenue Growth Rate (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue by Application (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Application (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Application (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Application in 2017
Table Global Human Embryonic Stem Cell (hESC) Revenue Forecast by Application (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Market Share Forecast by Application (2018-2023)
Figure Global Research Revenue Growth Rate (2013-2018)
Figure Global Clinical Trials Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Human Embryonic Stem Cell (hESC) Picture
Table Product Specifications of Human Embryonic Stem Cell (hESC)
Table Global Human Embryonic Stem Cell (hESC) and Revenue (Million USD) Market Split by Product Type
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Types in 2017
Figure Totipotent Stem Cell Picture
Figure Pluripotent Stem Cell Picture
Figure Unipotent Stem Cell Picture
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Application (2013-2023)
Figure Human Embryonic Stem Cell (hESC) Revenue Market Share by Applications in 2017
Figure Research Picture
Figure Clinical Trials Picture
Figure Others Picture
Table Global Market Human Embryonic Stem Cell (hESC) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (2013-2023)
Table Astellas Institute of Regenerative Medicine (US) Basic Information, Manufacturing Base and Competitors
Table Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Astellas Institute of Regenerative Medicine (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Asterias Biotherapeutics, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Asterias Biotherapeutics, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table BD Biosciences (US) Basic Information, Manufacturing Base and Competitors
Table BD Biosciences (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table BD Biosciences (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Cell Cure Neurosciences Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Type and Applications
Table Cell Cure Neurosciences Ltd. (Israel) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Cellular Dynamics International (US) Basic Information, Manufacturing Base and Competitors
Table Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Cellular Dynamics International (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare (UK) Basic Information, Manufacturing Base and Competitors
Table GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Type and Applications
Table GE Healthcare (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table MilliporeSigma (US) Basic Information, Manufacturing Base and Competitors
Table MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table MilliporeSigma (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table PerkinElmer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table PerkinElmer, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Life Sciences Ltd. (India) Basic Information, Manufacturing Base and Competitors
Table Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Type and Applications
Table Reliance Life Sciences Ltd. (India) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Research & Diagnostics Systems, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Research & Diagnostics Systems, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table SABiosciences Corp. (US) Basic Information, Manufacturing Base and Competitors
Table SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table SABiosciences Corp. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table STEMCELL Technologies, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Type and Applications
Table STEMCELL Technologies, Inc. (Canada) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Stemina Biomarker Discovery, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Stemina Biomarker Discovery, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio, Inc. (Japan) Basic Information, Manufacturing Base and Competitors
Table Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Type and Applications
Table Takara Bio, Inc. (Japan) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table TATAA Biocenter AB (Sweden) Basic Information, Manufacturing Base and Competitors
Table TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Type and Applications
Table TATAA Biocenter AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table Thermo Fisher Scientific, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table UK Stem Cell Bank (UK) Basic Information, Manufacturing Base and Competitors
Table UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Type and Applications
Table UK Stem Cell Bank (UK) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table ViaCyte, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Type and Applications
Table ViaCyte, Inc. (US) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Vitrolife AB (Sweden) Basic Information, Manufacturing Base and Competitors
Table Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Type and Applications
Table Vitrolife AB (Sweden) Human Embryonic Stem Cell (hESC) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Players (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Players (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Players in 2016
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Players in 2017
Figure Global Top 5 Players Human Embryonic Stem Cell (hESC) Revenue Market Share in 2017
Figure Global Top 10 Players Human Embryonic Stem Cell (hESC) Revenue Market Share in 2017
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Regions (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Regions in 2017
Figure North America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table North America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
Table North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure USA Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Canada Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Mexico Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Europe Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Germany Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure UK Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure France Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Russia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Italy Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure China Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Japan Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Korea Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure India Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table South America Human Embryonic Stem Cell (hESC) Revenue by Countries (2013-2018)
Table South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Brazil Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Argentina Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Colombia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure UAE Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Egypt Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure Nigeria Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Figure South Africa Human Embryonic Stem Cell (hESC) Revenue and Growth Rate (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) by Type (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Type (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Type (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Type in 2017
Table Global Human Embryonic Stem Cell (hESC) Revenue Forecast by Type (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Market Share Forecast by Type (2018-2023)
Figure Global Totipotent Stem Cell Revenue Growth Rate (2013-2018)
Figure Global Pluripotent Stem Cell Revenue Growth Rate (2013-2018)
Figure Global Unipotent Stem Cell Revenue Growth Rate (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue by Application (2013-2018)
Table Global Human Embryonic Stem Cell (hESC) Revenue Share by Application (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Application (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Share by Application in 2017
Table Global Human Embryonic Stem Cell (hESC) Revenue Forecast by Application (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Market Share Forecast by Application (2018-2023)
Figure Global Research Revenue Growth Rate (2013-2018)
Figure Global Clinical Trials Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Human Embryonic Stem Cell (hESC) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Europe Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure South America Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Human Embryonic Stem Cell (hESC) Revenue Market Forecast (2018-2023)
